COCP

Cocrystal Pharma, Inc.

Contracts

Total Value

Stock Metrics

4.2%

Short % Float

14.2d to cover · Moderate squeeze

5.8%

Inst % Float

10 holders · 2026-06-30

Vanguard Capital M

Top Holder

1.9% of float

9.1M sh

Public Float

74/100

Dilution Score

High

8 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

74/100

HIGH

Inst: 5.77% · Top: Vanguard Capital Management LLC

Biotech Analytics

Biotech / Pharma

21.14

Dilution Risk: HIGHSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk74

Clinical Trials17

Short Interest10